RU2828034C1 - METHOD FOR GENOTYPING POLYMORPHIC LOCUS rs196329 (AG) OF THE BAG3 GENE IN HUMAN BY REAL-TIME PCR USING ALLELE-SPECIFIC FLUORESCENT PROBES - Google Patents

Abstract

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology, particularly to a method for genotyping a polymorphic locus rs196329 (A>G) of the BAG3 gene in humans. Said method is carried out by real-time PCR, wherein the method involves identifying allelic variants of rs196329 (A>G) of the BAG3 gene using forward and reverse primers rs196329, characterized by sequences SEQ ID NO: 1 and SEQ ID NO: 2, respectively, as well as rs196329-A-allele-specific and rs196329-G-allele-specific fluorescent-labelled probes with sequences SEQ ID NO: 3 and SEQ ID NO: 4, respectively.

EFFECT: invention provides an easy-to-implement and cost-effective method of single-nucleotide polymorphism genotyping rs196329 (A>G) of the BAG3 gene by real-time PCR.

1 cl, 1 dwg

Description

Field of technology to which the invention relates

The invention relates to the field of biotechnology, molecular genetic diagnostics, in particular to the assessment of single nucleotide polymorphism rs196329 (A>G) of the BAG3 gene molecular genetic research method.

State of the art

BAG3 gene encodes a cochaperone for the chaperone proteins HSP70 and HSC70. It acts as a nucleotide exchange factor, promoting the release of ADP from the HSP70 and HSC70 proteins, thereby triggering the release of the client/substrate protein [Rauch, JN Non-canonical Interactions between heat shock cognate protein 70 (Hsc70) and Bcl2-associated anthanogene (BAG) Co-chaperones are important for client release / JN Rauch, ERP Zuiderweg, JE Gestwicki // Journal of Biological Chemistry. - 2016. - Vol. 291, No. 38. - P. 19848-19857]. It has antiapoptotic activity and plays a role in the nucleocytoplasmic transport of HSF1 [Jin YH, Ahn SG, Kim SA BAG3 affects the nucleocytoplasmic shuttling of HSF1 upon heat stress //Biochemical and Biophysical Research Communications. - 2015. - Vol. 464. - No. 2. - P. 561-567]. Diseases associated with BAG3 include myopathy and dilated cardiomyopathy [https://www.genecards.org/cgi-bin/carddisp.pl?gene=BAG3&keywords=BAG3].

The BAG3 gene (Gene ID: 9531) is localized on chromosome 10q26.11. According to SNPinfo Web Server/LD TAG SNP Selection [https://snpinfo.niehs.nih.gov/snpinfo/snptag.html], the polymorphic variant rs196329 of the BAG3 gene is target (i.e., a representative single nucleotide polymorphism in the genomic region with a high degree of linkage disequilibrium with groups of other polymorphic loci that make up the haplotype). Single nucleotide polymorphism rs196329, position chr10:119673041 (GRCh38.p14) [https://www.ncbi.nlm.nih.gov/snp/rs196329] is localized in the intron and is characterized by the substitution A>G,T. However, the T allele occurs with a frequency of <0.000001 in European populations and is also characterized by a low frequency in other populations of the world, which is why the A>G substitution is relevant for studies of multifactorial human diseases. SNP rs196329 is characterized by high functional significance. According to the bioinformatics resource GTEx Portal, the genetic variant rs196329 (A>G) affects the expression of the BAG3, TXNP1 genes in various organs and tissues through eQTL effects [https://gtexportal.org/home/snp/rs196329] . In addition, a significant association of rs196329 with histone modifications marking promoters and enhancers in various tissues was found [https://pubs.broadinstitute.org/mammals/haploreg/detail_v4.2.php?query=&id=rs196329]; the effect of this genetic variant on binding to transcription factors [http://atsnp.biostat.wisc.edu/search]. This creates a need for a simple to implement, inexpensive and accessible to researchers working in the field of genetic epidemiology, a method for identifying the rs196329 single nucleotide polymorphism of the BAG3 gene.

A method for analyzing genetic variations in the human genome by sequencing amplified DNA regions is known [Mardis E. R. DNA sequencing technologies: 2006-2016 //Nature protocols. - 2017. - Vol. 12. - No. 2. - P. 213-218]. The disadvantages of the method are the high cost of equipment and reagents, which excludes the widespread implementation of the method in experimental studies, especially the study of multifactorial diseases that require large sample sizes to ensure high research power.

A method for analyzing genetic variations in the human genome using matrix-assisted laser desorption ionization mass spectrometry (MALDI) is known. The method involves transferring the DNA to be analyzed onto a substrate where it crystallizes with the matrix. The crystallized analytes are then transferred and irradiated with a laser, causing desorption and ionization of the molecules in a vacuum chamber. Positively charged DNA ions are accelerated and migrate through the vacuum tube to a highly sensitive detector at different speeds depending on the mass of the ions, resulting in different times of flight. Using the time of flight of individual ionized DNA analytes, the system determines the mass and displays a mass spectrum identifying different genetic targets [Li D. et al. MALDI-TOF mass spectrometry in clinical analysis and research //ACS Measurement Science Au. - 2022. - Vol. 2. - No. 5. - P. 385-404]. The disadvantages of the method are labor intensity, high cost of equipment, high cost of the experiment, and the need for highly qualified personnel.

The commercial genotyping kit rs196329 (A/G) BAG3 (Assay C____991586_1_; catalog 4351379) from ThermoFisher was chosen as a prototype. However, genotyping using commercial kits is characterized by high cost, and information on the structure of the primers and allele-specific probes required for PCR is closed to researchers, and therefore it cannot be reproduced with a standard set of equipment and reagents.

Thus, there is a real need to create a rapid, inexpensive and easily reproducible method for identifying the rs196329 (A>G) polymorphism of the BAG3 gene, with a structure of primers and allele-specific probes available to all researchers, which could be used as a “routine” genotyping method in any PCR laboratory.

Disclosure of the essence of the invention

The technical result of this invention is the development of a simple to implement and economically feasible method for genotyping the single nucleotide polymorphism rs196329 (A>G), localized in position chr10:119673041 (GRCh38.p14) of the BAG3 gene (Gene ID: 9531) by the polymerase chain reaction method in "real time" mode using allele-specific signal probes containing FAM and ROX fluorophores.

The technical result is achieved in that the identification of allelic variants of rs196329 (A>G) of the BAG3 gene is carried out using the forward primer rs196329 5′-AGTGTCCACCACACCCTTTC-3′ (SEQ ID NO 1), the reverse primer rs196329 5′-GGTTCAGCATGGGCAAAG-3′ (SEQ ID NO 2), the rs196329-A-allele-specific fluorescently labeled probe 5′-(FAM)TCACCTTCC A CTCAGTTAC(RTQ1)-3′ (SEQ ID NO 3),

rs196329-G allele-specific fluorescently labeled probe 5′-(ROX)TCACCTTCC G CTCAGTTAC(BHQ2)-3′ (SEQ ID NO 4).

The invention is explained by the following figure: discrimination of alleles at the rs196329 locus of the BAG3 gene during genotyping by the PCR method in "real time" mode using allele-specific fluorescent probes according to RFU (relative fluorescence units) values on a CFX96 amplifier: rs196329-A/A genotypes are shown as orange circles, rs196329-A/G genotypes are shown as green triangles, rs196329-G/G genotypes are shown as blue squares; the negative control is marked with a black diamond.

The work on the design of oligonucleotides included several stages:

1) Using the open database Ensembl genome browser 109 [https://www.ensembl.org/index.html], a sequence flanking the desired single nucleotide substitution [A/G] rs196329 BAG3 was selected, and then, using the available online software Primer3web version 4.1.0 [https://primer3.ut.ee/], the sequence of oligonucleotides used to carry out the PCR reaction was selected:

forward common primer rs196329 5′-AGTGTCCACCACACCCTTTC-3′ (SEQ ID NO 1),

reverse common primer rs196329 5′-GGTTCAGCATGGGCAAAG-3′ (SEQ ID NO 2).

The size of the BAG3 gene fragment amplified during PCR is 164 nucleotide pairs.

(AGTGTCCACCACACCCTTTCAGGGCTCTTCACACCCCCATCCACACCGCAGC

CACAGCCTCACCTTGGGTGTAGGCAGTGTGTCACCTTCC [A/G] CTCAGTTACC

CACTCCACTCTGCAGGCCCATTCTGCTCATTCCCACCCCTGTGCCTTTTGCCC

ATGCTGAACC).

2). The design of probes was based on practical recommendations [Basu C. (ed.). PCR primer design. - New York : Humana Press, 2015]. Hydrolysis probes were used in the reaction. The probe sequence was selected so that it annealed to the matrix between the forward and reverse primers. Each probe was equipped with a fluorophore and a fluorescence quencher, the absorption spectrum of which corresponded to the wavelengths of the fluorophore spectrum. The RTQ1 quencher was used to quench FAM fluorescence; the BHQ2 quencher was used to quench ROX fluorescence.

Based on the stated criteria and practical recommendations, probes with the following structure were selected:

rs196329-A-allele-specific fluorescently labeled probe 5′-(FAM)TCACCTTCC A CTCAGTTAC(RTQ1)-3′(SEQ ID NO 3),

rs196329-G allele-specific fluorescently labeled probe 5′-(ROX)TCACCTTCC G CTCAGTTAC(BHQ2)-3′ (SEQ ID NO 4).

3) The production of primers and probes was carried out at the service center of NPK Sintol, Moscow.

4) Using practical experiments, optimal conditions for genotyping were selected, which include the following steps: 50°C for 2 minutes, 95°C for 10 minutes, then 39 cycles [95°C for 10 seconds and 59°C for 1 minute].

5) The developed method was tested in the laboratory of genomic studies on 200 DNA samples of healthy individuals of the biobank of the Research Institute of Genetic and Molecular Epidemiology of KSMU. Genotyping was carried out according to the RFU (relative fluorescence units) values of probes with fluorescent dyes. According to the results of rs196329 genotyping, 13 individuals (6.5%) were homozygotes for the A allele (genotype A/A); 74 individuals (37%) were heterozygotes (genotype A/G), 113 individuals (56.5%) were homozygotes for the G allele (genotype G/G).

6) The method was validated by mass spectrometric analysis on a MassArray analyzer 4 genomic time-of-flight mass spectrometer (Agena Bioscience). The results of both genotyping methods were completely (100% of genotypes) identical. However, the patented method of genotyping the polymorphic locus rs196329 (A>G) of the BAG3 gene by PCR in "real time" mode using allele-specific probes allows to significantly (by 6 hours) reduce the analysis time, and also reduces the cost of the analysis (by 4-5 times).

Implementation of the invention

The method is carried out as follows:

1. Isolation of DNA from peripheral venous blood. In the first step, 0.5 ml of PBS was added to 0.5 ml of blood and centrifuged for 10 min at 12 thousand rpm. The supernatant was poured off, 1 ml of PBS was added and centrifuged again under the same conditions. The supernatant was decanted, 200 μl of TE buffer was added, the mixture was pipetted until the sediment dissolved, and then 10 μl of 1% sodium dodecyl sulfate (SDS) solution and 5 μl of proteinase K were successively added. The tubes were incubated in a thermostat at t=37°C for 12 h. During the second stage, four successive centrifugations with phenol and chloroform were carried out according to the protocol of the method (10 min, 8 thousand rpm), after which the DNA was precipitated with an ice-cold solution of 95% ethyl alcohol and centrifuged for 10 min at 14.3 thousand rpm. After evaporation of the alcohol, the DNA was dissolved in 100 μl of deionized distilled water. The resulting DNA solution in water had a purity in the range of A260/280=1.5-2.0 and an average concentration of about 180-200 ng/μl.

2. Preparation of DNA samples for genotyping. The quality of the isolated DNA was assessed by the degree of purity and concentration of the solution using a NanoDrop spectrophotometer (Thermo Fisher Scientific, USA). All analyzed DNA samples were diluted with deionized water to a concentration of 15-20 ng/µl at A260/280=1.5-2.0.

3. Analysis of the rs196329 (A>G) polymorphism of the BAG3 gene using real-time polymerase chain reaction with allele-specific probes. For genotyping, two flanking primers were used, forward (SEQ ID NO 1) and reverse (SEQ ID NO 2), as well as allele-specific probes: A-allele-specific fluorescently labeled probe (SEQ ID NO 3), G-allele-specific fluorescently labeled probe (SEQ ID NO 4).

Real-time PCR was performed in a 25 ml reaction mixture containing 1.25 U Hot Start Taq DNA polymerase (Biolabmix, Novosibirsk, Russia), 20 ng DNA, 10 μM of each primer, 5 μM of each probe, 0.03 mM of each dNTP, 3.0 mM MgCl2; 1xPCR buffer [67 mM Tris-HCl, pH 8.8, 16.6 mM (NH4)2SO4, 0.01% Tween-20]. The amplification reaction consisted of a heating step to 50°C for 2 min, 95°C for 10 min, then 39 cycles [95°C for 10 sec and 59°C for 1 min].

4. Genotyping. When performing PCR in a fluorescent detection amplifier (Bio-Rad CFX96 or similar amplifier), genotyping is performed based on RFU (relative fluorescence units) values. For rs196329 (A>G) of the BAG3 gene, the probe with the fluorescent dye FAM corresponds to the A allele, and the probe with the dye ROX corresponds to the G allele (Fig. 1). The figure shows a clear division of the samples into clusters, where the black diamond corresponds to the negative control, the cluster of orange circles corresponds to the probe with the fluorescent dye FAM and allows identification of A/A homozygotes. The cluster of blue squares corresponds to the probe with the dye ROX and allows identification of G/G homozygotes. The cluster of green triangles corresponds to the accumulation of the fluorescence level for both probes and allows identification of A/G heterozygotes.

Resume.

Thus, an effective and inexpensive method for rapid identification of the polymorphic variant rs196329 (A>G) of the BAG3 gene in humans by PCR in real time using allele-specific fluorescent probes has been developed, which can be used in medicine to determine hereditary predisposition to the development of diseases associated with the carriage of BAG3 gene polymorphisms, as well as for scientific purposes.

--->

<?xml version="1.0" encoding="UTF-8"?>

<!DOCTYPE ST26SequenceListing PUBLIC "-//WIPO//DTD Sequence

Listing 1.3//EN" "ST26SequenceListing_V1_3.dtd">

<ST26SequenceListing dtdVersion="V1_3" fileName="Method

genotyping of the polymorphic locus rs196329 (A G) of the BAG3 gene in

human by the PCR method in "real time" mode using

allele-specific fluorescent probes.xml"

softwareName="WIPO Sequence" softwareVersion="2.3.0"

productionDate="2024-02-26">

<ApplicationIdentification>

<IPOfficeCode>RU</IPOfficeCode>

<ApplicationNumberText></ApplicationNumberText>

<FilingDate></FilingDate>

</ApplicationIdentification>

<ApplicantFileReference>1876</ApplicantFileReference>

<ApplicantName languageCode="ru">Federal State

budgetary educational institution of higher education

&quot;Kursk State Medical University&quot;

Ministry of Health of the Russian Federation,</ApplicantName>

<ApplicantNameLatin>Kursk State Medical

University</ApplicantNameLatin>

<InventionTitle languageCode="en">Genotyping method

polymorphic locus rs196329 (A&gt;G) of the BAG3 gene in humans by the method

Real-time PCR using allele-specific

fluorescent probes</InventionTitle>

<SequenceTotalQuantity>4</SequenceTotalQuantity>

<SequenceData sequenceIDNumber="1">

<INSDSeq>

<INSDSeq_length>20</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..20</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q2">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>agtgtccaccacccctttc</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

<SequenceData sequenceIDNumber="2">

<INSDSeq>

<INSDSeq_length>18</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..18</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q4">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>ggttcagcatgggcaaag</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

<SequenceData sequenceIDNumber="3">

<INSDSeq>

<INSDSeq_length>19</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..19</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q6">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>tcaccttccactcagttac</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

<SequenceData sequenceIDNumber="4">

<INSDSeq>

<INSDSeq_length>19</INSDSeq_length>

<INSDSeq_moltype>DNA</INSDSeq_moltype>

<INSDSeq_division>PAT</INSDSeq_division>

<INSDSeq_feature-table>

<INSDFeature>

<INSDFeature_key>source</INSDFeature_key>

<INSDFeature_location>1..19</INSDFeature_location>

<INSDFeature_quals>

<INSDQualifier>

<INSDQualifier_name>mol_type</INSDQualifier_name>

<INSDQualifier_value>other DNA</INSDQualifier_value>

</INSDQualifier>

<INSDQualifier id="q8">

<INSDQualifier_name>organism</INSDQualifier_name>

<INSDQualifier_value>synthetic construct</INSDQualifier_value>

</INSDQualifier>

</INSDFeature_quals>

</INSDFeature>

</INSDSeq_feature-table>

<INSDSeq_sequence>tcaccttccgctcagttac</INSDSeq_sequence>

</INSDSeq>

</SequenceData>

</ST26SequenceListing>

<---

Claims (1)

A method for genotyping the polymorphic locus rs196329 (A>G) of the BAG3 gene in humans by the PCR method in the "real time" mode using allele-specific fluorescent probes, characterized in that the identification of the allelic variants of rs196329 (A>G) of the BAG3 gene is carried out using the forward primer rs196329 5′-AGTGTCCACCACACCCTTTC-3′ (SEQ ID NO 1), the reverse primer rs196329 5′-GGTTCAGCATGGGCAAAG-3′ (SEQ ID NO 2), the rs196329-A-allele-specific fluorescently labeled probe 5′-(FAM)TCACCTTCC A CTCAGTTAC(RTQ1)-3′ (SEQ ID NO 3), rs196329-G allele-specific fluorescently labeled probe 5′-(ROX)TCACCTTCC G CTCAGTTAC(BHQ2)-3′ (SEQ ID NO 4).